UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

312 NEUROENDOCRINE EVALUATION OF A PATIENT WITH KEARNS SAYRE SYNDROME (KSS)

Pediatric research, 1978-04, Vol.12, p.415-415

1978

Volltextzugriff (PDF)

GLUCAGON: AN EFFECTOR OF ACTH, CORTISOL (F), AND GROWTH HORMONE RELEASE

Pediatric research, 1977-04, Vol.11 (4), p.428-428

1977

Volltextzugriff (PDF)

Glucagon stimulation test (GST): Its effect on glucose homeostasis and growth hormone release in the normal and hypopituitary patient

Pediatric research, 1971-08, Vol.5 (8), p.398-398

1971

Volltextzugriff (PDF)

537 HYPOPHOSPHATASIA (A FAMILY STUDY) AND TURNER SYNDROME

Pediatric research, 1978-04, Vol.12, p.453-453

1978

Volltextzugriff (PDF)

NEONATAL INTERVENTION IN TYPE I GLYCOGEN STORAGE DISEASE (GSD)

Pediatric research, 1977-04, Vol.11 (4), p.518-518

1977

Volltextzugriff (PDF)

THE MECKEL-GRUBER (MGS)/ULLRICH-FEICHTIGER (UFS) SYNDROME: ANTEMORTEM HORMONAL STUDIES

Pediatric research, 1977-04, Vol.11 (4), p.526-526

1977

Volltextzugriff (PDF)

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment

Leukemia, 2017-07, Vol.31 (7), p.1570-1581

2017

Volltextzugriff (PDF)

Gonadal function in mosaic XO or XX/XY Turner's syndrome

Pediatric research, 1971-08, Vol.5 (8), p.423-423

1971

Volltextzugriff (PDF)

A new hypoglycemic syndrome: Fasting and reactive hypoglycemia, nomal growth and deficient plasma growth hormone (HGH)

Pediatric research, 1971-08, Vol.5 (8), p.396-397

1971

Volltextzugriff (PDF)

The oomycete Lagenisma coscinodisci hijacks host alkaloid synthesis during infection of a marine diatom

Nature communications, 2019-10, Vol.10 (1), p.4938-8, Article 4938

2019

Volltextzugriff (PDF)

A metabolica and anatomic study of a case of Noonan's syndrome with intestinal lymphangiectasia

Pediatric research, 1971-08, Vol.5 (8), p.389-389

1971

Volltextzugriff (PDF)

An epithelial serine protease activates the amiloride-sensitive sodium channel

Nature (London), 1997-10, Vol.389 (6651), p.607-610

1997

Volltextzugriff (PDF)

Author Correction: The oomycete Lagenisma coscinodisci hijacks host alkaloid synthesis during infection of a marine diatom

Nature communications, 2020-03, Vol.11 (1), p.1698-1698, Article 1698

2020

Volltextzugriff (PDF)

Quantitative pathogenicity and host adaptation in a fungal plant pathogen revealed by whole-genome sequencing

Nature communications, 2024-03, Vol.15 (1), p.1933-1933, Article 1933

2024

Volltextzugriff (PDF)

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition

Oncogene, 2010-04, Vol.29 (16), p.2325-2336

2010

Volltextzugriff (PDF)

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma

Leukemia, 2009-05, Vol.23 (5), p.961-970

2009

Volltextzugriff (PDF)

Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy

Leukemia, 2013-08, Vol.27 (8), p.1715-1721

2013

Volltextzugriff (PDF)

Nanosized food additives impact beneficial and pathogenic bacteria in the human gut: a simulated gastrointestinal study

NPJ science of food, 2018-01, Vol.2 (1), p.22-22, Article 22

2018

Volltextzugriff (PDF)

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway

Leukemia, 2007-03, Vol.21 (3), p.535-540

2007

Volltextzugriff (PDF)

Inhibition of post-ischemic brain injury by clusterin overexpression

Nature medicine, 2001-09, Vol.7 (9), p.977-978

2001

Volltextzugriff (PDF)

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3[beta] activation and RNA polymerase II inhibition

Oncogene, 2010-04, Vol.29 (16), p.2325

2010

Volltextzugriff (PDF)

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3b activation and RNA polymerase II inhibition

Oncogene, 2010-04, Vol.29 (16), p.2325-2336

2010

Volltextzugriff (PDF)

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of -catenin TCF pathway

Leukemia, 2007-03, Vol.21 (3), p.535-540

2007

Volltextzugriff (PDF)

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of b-catenin/TCF pathway

Leukemia, 2007-03, Vol.21 (3), p.535-540

2007

Volltextzugriff (PDF)

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition

Oncogene, 2010-04, Vol.29 (16), p.2325

2010

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Nexis Uni
(24)
EZB Electronic Journals Library
(23)
Journals@Ovid Ovid Full Text
(20)
Publisher website
(11)
MEDLINE
(9)
Ingenta
(5)
Psychology & Behavioral Sciences Collection (EBSCO)
(1)
IngentaConnect Journals
(1)

3 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

312 NEUROENDOCRINE EVALUATION OF A PATIENT WITH KEARNS SAYRE SYNDROME (KSS)

GLUCAGON: AN EFFECTOR OF ACTH, CORTISOL (F), AND GROWTH HORMONE RELEASE

Glucagon stimulation test (GST): Its effect on glucose homeostasis and growth hormone release in the normal and hypopituitary patient

537 HYPOPHOSPHATASIA (A FAMILY STUDY) AND TURNER SYNDROME

NEONATAL INTERVENTION IN TYPE I GLYCOGEN STORAGE DISEASE (GSD)

THE MECKEL-GRUBER (MGS)/ULLRICH-FEICHTIGER (UFS) SYNDROME: ANTEMORTEM HORMONAL STUDIES

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment

Gonadal function in mosaic XO or XX/XY Turner's syndrome

A new hypoglycemic syndrome: Fasting and reactive hypoglycemia, nomal growth and deficient plasma growth hormone (HGH)

The oomycete Lagenisma coscinodisci hijacks host alkaloid synthesis during infection of a marine diatom

A metabolica and anatomic study of a case of Noonan's syndrome with intestinal lymphangiectasia

An epithelial serine protease activates the amiloride-sensitive sodium channel

Author Correction: The oomycete Lagenisma coscinodisci hijacks host alkaloid synthesis during infection of a marine diatom

Quantitative pathogenicity and host adaptation in a fungal plant pathogen revealed by whole-genome sequencing

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma

Lenalidomide in combination with an activin A-neutralizing antibody: preclinical rationale for a novel anti-myeloma strategy

Nanosized food additives impact beneficial and pathogenic bacteria in the human gut: a simulated gastrointestinal study

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway

Inhibition of post-ischemic brain injury by clusterin overexpression

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3[beta] activation and RNA polymerase II inhibition

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3b activation and RNA polymerase II inhibition

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of -catenin TCF pathway

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of b-catenin/TCF pathway

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition

Aktive Filter

Suchergebnisse filtern